Skip to content

Comparison of Respiratory Muscle, Pain, Functional Performance and Cognitive Status in Obstructive Lung Diseases

Assessment of Cognitive Status, Pain, Functional Status, Postural Awareness, Respiratory Muscle Strength and Endurance in Obstructive Pulmonary Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04048408
Enrollment
63
Registered
2019-08-07
Start date
2019-01-01
Completion date
2020-06-24
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Functional Disturbance, Obstructive Pulmonary Disease, Pain, Chronic

Brief summary

In the literature, there are a limited number of studies evaluating postural awareness, cognitive status, respiratory muscle strength and endurance, functional capacity, and pain in people with obstructive pulmonary disease, and comparing these parameters with each other and with healthy subjects, and most of the studies are on chronic obstructive pulmonary disease patients. There we will evaluate these parameters in different obstructive lung diseases and compare the findings of healthy individuals.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

for obstructive lung diseases 1. To be diagnosed with obstructive pulmonary disease, 2. Have not experienced acute exacerbation in the last 3 months, 3. Being between the ages of 18-65, 4. Not having chronic pain problems, 5. Volunteer for research, 6. To be able to walk and cooperate.

Exclusion criteria

for obstructive lung diseases 1. To be able to diagnose neurological disorder, 2. To have an advanced orthopedic disease that may affect functional capacity measurement. Criteria for Non-Inclusion for healthy group 1. To have any cardiopulmonary disease, 2. To have an advanced orthopedic disease that may affect functional capacity measurement.

Design outcomes

Primary

MeasureTime frameDescription
Pain Perception01.01.2019-31.08.2019Pain Perception Threshold and Tolerance With Algometer

Secondary

MeasureTime frameDescription
Cognitive Function Assessment01.01.2019-31.08.2019Montreal Cognitive Assessment Test (MoCA)
Functional capacity assesment01.01.2019-31.08.20196 minute walk test
Postural awareness assesment01.01.2019-31.08.2019Body Awareness Questionnare is a likert type questionnare and total score ranges from 18-126. Higher scores mean better body awareness level
Respiratory muscle strength and endurance measurement01.01.2019-31.08.2019Mouth pressure measurement

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026